Professor Fabienne Mackay Related News
How molecules out of balance lead to human multiple myeloma and other cancers
MEDIA RELEASE:
29 Jul 2008
An international team of scientists, from Garvan, Harvard Medical School and the Max Planck Institute in Germany, has identified processes that are heavily implicated in human multiple myeloma and other B cell cancers, moving us closer to developing quick tests and readouts that could help in the tailored treatment of patients.
Uncovering the mysteries behind heart defects
27 Aug 2007
Until now, the reasons why some children are born with holes in their hearts, or faulty heart valves, have eluded doctors and scientists. Professor Fabienne Mackay, Director of Garvan's Autoimmunity Research Unit, is hopeful that her findings, published online in the August edition of the prestigious PNAS journal, may hold at least some of the answers.
Have we uncovered a new form of Lupus?
31 Jul 2007
Findings published in the July edition of the prestigious Journal of Experimental Medicine may offer new hope to people suffering from a previously unsuspected form of lupus. The research, undertaken by Garvan's Professor Fabienne Mackay, suggests a form of the disease that does not respond to current treatments. If proven to be correct, her findings will change clinical thinking and so bring about changes in patient management and in clinical trial protocols.
Garvan receives equipment grant from the Lupus Association of NSW
03 Feb 2006
Professor Fabienne Mackay and her team from the Arthritis and Immunology program have been awarded a $55 000 grant by the NSW Lupus Association
Garvan researchers explain how stress makes us sick
05 Dec 2005
Garvan Institute scientists have discovered how a hormone known as neuropeptide Y (NPY) can prevent our immune system functioning properly paving the way for new opportunities for therapeutic intervention.
